Canadian regulators have approved a drug for treating a condition that affects up to three-quarters of women and causes excessive bleeding from the uterus.
Mylan Specialty has appointed Roger Graham as president, the Mylan subsidiary said Monday.
Becton, Dickinson and Co. has launched a needle that it said would make insulin injections easier and faster for people with diabetes.
The Food and Drug Administration has approved a contraceptive pill for all women of childbearing potential without a prescription, the agency said.
Under a new law, pharmacists in Indiana will be able to provide an expanded range of immunizations that includes human papillomavirus.
Pharmaceutical wholesaler H.D. Smith will buy a majority interest in a Cincinnati-based patient assistance, pharmaceutical brand support and reimbursement company.
A large majority of Americans are taking prescription drugs, according to a new study by the Mayo Clinic.
Three new drugs for Type 2 diabetes made by Takeda Pharmaceutical have become available in pharmacies, the company said.
Target Corp. is reaching out to Canadian customers preparing to send their children to summer camp with information and resources about allergies.
Royalty Pharma will not buy Irish drug maker Elan Corp., the company said Tuesday.